Article Details

Goldfinch Bio Announces Initiation of Open-Label Extension Study for Patients with Focal ...

Retrieved on: 2021-08-10 12:11:15

Tags for this article:

Click the tags to see associated articles and topics

Goldfinch Bio Announces Initiation of Open-Label Extension Study for Patients with Focal .... View article details on hiswai:

Excerpt

Goldfinch Bio, a clinical stage biotechnology company focused on discovering and developing precision medicines for the treatment of kidney ...

Article found on: www.valdostadailytimes.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up